Alumni

Call for expressions of interest | Summer 2026 Internship

rachel.mutombo@mcgill.ca — Tue, 18 Nov 2025 16:07:32 +0000

D2R is excited to announce this brand new opportunity for internships to Black undergraduate students in summer 2026 in partnership with COUHR. COUHR is a student-run non-profit organization partnering with research institutions across Canada to provide funded summer internships for underrepresented undergraduate students in fields such as neuroscience, biophysics, and genetics.

EDI Workshop: Mental Health in Highly Performant Environments

roberta.santangelo@mcgill.ca — Wed, 12 Nov 2025 21:48:11 +0000

Mental health in high-performing research environments is a shared responsibility and a growing challenge we must address together.

EDI Workshop: Mental Health in Highly Performant Environments

roberta.santangelo@mcgill.ca — Thu, 13 Nov 2025 14:00:35 +0000

Mental health in high-performing research environments is a shared responsibility and a growing challenge we must address together.

Every professor, student, research staff, and administrative staff can play a vital role in creating healthy, supportive, and inclusive research spaces. This includes standing by colleagues who disclose their disabilities and ensuring everyone can thrive.

Event | BBME seminar series: Prof. David R. Walt (Harvard Medical School)

roberta.santangelo@mcgill.ca — Fri, 14 Nov 2025 21:59:43 +0000

Hybrid Event | D2R Investor Series: Venture Capital Demystified - Investment Insights with Inès Holzbaur

roberta.santangelo@mcgill.ca — Mon, 10 Nov 2025 15:17:23 +0000

7th Quebec Annual Extracellular Vesicle Workshop (QEVW2025)

roberta.santangelo@mcgill.ca — Wed, 12 Nov 2025 15:52:56 +0000

The 7th Annual Quebec Extracellular Vesicles Workshop (QEVW2025) is just around the corner!

Call for Summer 2026 Internship Supervisors

rachel.mutombo@mcgill.ca — Mon, 10 Nov 2025 20:11:34 +0000

D2R and the Canadian Organization for Undergraduate Health Research launch a call for applications for a new internship opportunity

D2R is excited to announce this brand new opportunity to for internships Black undergraduate students in summer 2026. D2R has partnering COUHR to offer funded summer research internships in genomic-based RNA therapeutics for Black undergraduate students from across universities in Montreal.

Hybrid Event | D2R Investor Series: Venture Capital Demystified - Investment Insights with Inès Holzbaur

roberta.santangelo@mcgill.ca — Mon, 10 Nov 2025 15:52:58 +0000

Every year, billions of dollars are invested by funding agencies in basic and translational research, yet the path from academic discovery to private investment necessary for the creation of new companies is rarely straightforward. In this seminar, you'll get an inside look at how investors work, what makes a research idea stand out to venture capitalists, and how they evaluate translational value of scientific opportunities. By the end of the session, you’ll have a clearer grasp of the framework needed to transition an idea or mechanism discovered in the lab to an investment phase.

Event | Introduction to Applying Equity, Diversity and Inclusion in Genomic-Based RNA Therapeutics Research

rachel.mutombo@mcgill.ca — Tue, 14 Oct 2025 19:35:13 +0000

Join D2R for a learning opportunity to gain foundational knowledge and practical tools to embed Equity, Diversity and Inclusion (EDI) into your genomic-based RNA therapeutics research. Through engaging discussions and activities, participants will explore key EDI definitions, examine both opportunities and challenges in the field, and learn best practices for inclusive research design.

D2R awards over $5.3 million in Foundational and Research in Motion funding programs

rachel.mutombo@mcgill.ca — Thu, 06 Nov 2025 15:05:23 +0000

Montreal – November 6, 2025 | The DNA to RNA (D2R) initiative at 91�� is proud to announce the recipients of the second cycle of the Foundational and Research in Motion (RIM) funding programs.

From common diseases affecting millions, such as lung cancer, to rare disorders like lipodystrophy, this investment of over 5.3 million dollars reflects D2R’s commitment to advancing bold ideas and fostering interdisciplinary collaboration across the discovery-to-implementation spectrum.

Genomic Medicine and Indigenous Health Award: Celebrating Excellence in Research

roberta.santangelo@mcgill.ca — Mon, 27 Oct 2025 18:09:10 +0000

On October 23, at the 2025 Rendez-Vous Génome Québec in Montréal, Professor Treena Wasonti:io Delormier was announced as the recipient of the D2R Genomic Medicine and Indigenous Health Award.

Video | Indigenous Engagement at D2R

rachel.mutombo@mcgill.ca — Fri, 17 Oct 2025 14:54:13 +0000

D2R is deeply committed to fostering Indigenous leadership within the realms of genomic medicine, RNA therapeutics and health inequities. We believe research is strongest when it is guided by respect, collaboration and trust. Our approach both respects and relies on Indigenous governance structures and ethics to guide project development, data management, and dissemination of results, ensuring outcomes are beneficial and aligned with the priorities of Indigenous communities.

EDI Internship Opportunity – Winter 2026

rachel.mutombo@mcgill.ca — Mon, 20 Oct 2025 17:03:40 +0000

D2R and the Department of Equity, Ethics and Policy launch a call for applications for an EDI Internship Opportunity

Hybrid Event | D2R Investor Series Transform your science into a new Biotech company - Investment Insights with Medicxi

roberta.santangelo@mcgill.ca — Fri, 17 Oct 2025 03:30:50 +0000

Hybrid Event | D2R Investor Series Transform your science into a new Biotech company - Investment Insights with Medicxi

roberta.santangelo@mcgill.ca — Fri, 17 Oct 2025 03:33:50 +0000

Every year, billions of dollars are invested by funding agencies in basic and translational research, yet the path from academic discovery to private investment necessary for the creation of new companies is rarely straightforward. In this seminar, you’ll get an inside look at how investors work, what makes a research idea stand out to venture capitalists, and how they evaluate translational value of scientific opportunities. By the end of the session, you’ll have a clearer grasp of the framework needed to transition an idea or mechanism discovered in the lab to an investment phase.